Cite
HARVARD Citation
Corty, R. et al. (2020). Antibacterial Use Is Associated with an Increased Risk of Hematologic and Gastrointestinal Adverse Events in Patients Treated with Gemcitabine for Stage IV Pancreatic Cancer. Oncologist. pp. 579-584. [Online].